BBLGW
Bone Biologics Corp WarrantsNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-0.14
Beta
0.53
52W High
$35.95
52W Low
$6.80
50-Day MA
$14.59
200-Day MA
$18.07
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Bone Biologics Corp Warrants
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using recombinant human protein. The company is headquartered in Burlington, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -75.40% |
| Return on Assets | -46.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.60 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $1.79M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
0.00%
HV 20-Day
54.11%
HV 30-Day
117.48%
HV 60-Day
122.20%
HV Rank
—
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BBLGW and any ticker you trade — then tracks every position and per-strategy win rate.
Data last updated: 7/29/2026